1. Home
  2. VREX vs STRO Comparison

VREX vs STRO Comparison

Compare VREX & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$10.98

Market Cap

447.2M

Sector

Technology

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$22.94

Market Cap

381.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
STRO
Founded
2016
2003
Country
United States
United States
Employees
N/A
133
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
447.2M
381.1M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
VREX
STRO
Price
$10.98
$22.94
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$16.67
$31.33
AVG Volume (30 Days)
466.3K
441.4K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$811,000,000.00
N/A
Revenue This Year
$5.35
N/A
Revenue Next Year
$3.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.76
$0.72
52 Week High
$14.57
$43.85

Technical Indicators

Market Signals
Indicator
VREX
STRO
Relative Strength Index (RSI) 57.73 34.27
Support Level $10.88 $19.11
Resistance Level $12.62 $27.96
Average True Range (ATR) 0.47 2.14
MACD 0.01 -0.55
Stochastic Oscillator 80.33 10.83

Price Performance

Historical Comparison
VREX
STRO

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: